UNSPSC 51131824: Camostat mesilate or mesylate

This classification denotes a protease inhibitor with the molecular formula C20H22N4O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 451M50A1EQ, chemically known as p-(p-guanidinobenzoyloxy)phenyl acetic acid, n,n-dimethylcarbamoylmethyl ester but more generally known as camostat mesilate, which bears US NIH Compound Identifier 43071. European Medicines Agency schedules Camostat mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01007MIG.

Most nations, for tariff and trade purposes, schedule camostat mesylate under HS 29252900. As of Q4 2014, CAMOSTAT MESYLATE remains US FDA's Preferred Term for this commodity. Camostat mesylate bears US NLM identifiers UMLS ID C0060700 and NCI Concept Code C96364. SMILES: CN(C)C(=O)COC(=O)CC1CCC(CC1)OC(=O)C2CCC(CC2)NC(=N)N.CS(=O)(=O)O.

UNSPSC 51131824 Camostat mesilate or mesylate is a Commodity code that shows minimal alignment between its pharmaceutical designation and recent state and local procurement activity. The single identifiable recent opportunity tagged to this code is Sourcewell RFP #061626, a cooperative purchasing initiative for law enforcement equipment, which falls entirely outside the scope of a pharmaceutical compound used in clinical settings. State and local agencies do not appear to be soliciting camostat mesilate or mesylate directly under this code; the mismatch suggests either a classification error in the opportunity record or dormancy in the code's actual use within state and local procurement systems.

Sourcewell, a Minnesota local government cooperative purchasing unit, issued RFP #061626 on behalf of participating entities including Franklin, Grant, Grays Harbor, Chelan, and Yakima counties in Washington state, with proposals due June 16, 2026. The cooperative framework is designed to serve thousands of governmental agencies, higher education institutions, K-12 school districts, nonprofit organizations, tribal governments, and public entities across the United States and Canada. No recent opportunities specifically soliciting pharmaceutical compounds, camostat mesilate or mesylate, or related clinical supplies appear in the available state and local procurement record. This code does not currently represent active state and local buying activity.